Oragenics Inc (OGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2016 | 12-2015 | 09-2015 | 06-2015 | 03-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,063 | -11,711 | -9,492 | -7,628 | -1,293 |
| Depreciation Amortization | 18 | 71 | 53 | 33 | 14 |
| Accounts receivable | N/A | N/A | N/A | N/A | -14 |
| Other Working Capital | 219 | 417 | 254 | 21 | -122 |
| Other Operating Activity | 206 | 6,033 | 5,658 | 5,386 | 126 |
| Operating Cash Flow | $-1,620 | $-5,190 | $-3,528 | $-2,188 | $-1,288 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -101 | -101 | -94 | -72 |
| Investing Cash Flow | $N/A | $-101 | $-101 | $-94 | $-72 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | -34 | -160 | -114 | -80 | -35 |
| Financing Cash Flow | $-34 | $-160 | $-114 | $-80 | $-35 |
| Beginning Cash Position | 5,083 | 10,449 | 10,449 | 10,449 | 10,449 |
| End Cash Position | 3,368 | 5,083 | 6,739 | 8,044 | 9,054 |
| Net Cash Flow | $-1,716 | $-5,366 | $-3,710 | $-2,405 | $-1,396 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,620 | -5,190 | -3,528 | -2,188 | -1,288 |
| Capital Expenditure | N/A | -103 | -103 | -94 | -72 |
| Free Cash Flow | -1,620 | -5,292 | -3,630 | -2,282 | -1,361 |